aluates Reports

$ 0.0

Automative

Global Microbiome Therapeutics Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-38U12682

Global Microbiome Therapeutics Sales Market Report 2023

BUY CHAPTERS

Global Microbiome Therapeutics Market Research Report 2025

Code: QYRE-Auto-38U12682

Report

August 2025

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Seres Therapeutics

Assembly Biosciences

Synthetic Biologics

PureTech

Synlogic

Enterome BioScience

4D Pharma

Second Genome

C3 Jian

Rebiotix

MicroBiome Therapeutics LLC

Metabiomics

Ritter Pharmaceuticals

Symberix

OpenBiome

Azitra

Symbiotix Biotherapies

Metabogen

Finch Therapeutics

Ferring

Vedanta Biosciences

Microbiome Therapeutics Market Size

The global market for Microbiome Therapeutics was valued at US$ 568 million in the year 2024 and is projected to reach a revised size of US$ 3351 million by 2031, growing at a CAGR of 30.5% during the forecast period.

Microbiome Therapeutics Market

Microbiome Therapeutics refers to novel therapeutic approaches that utilize modulation of the human microbiome—especially gut microbiota—to treat or prevent diseases. These therapies include live biotherapeutic products (LBPs), fecal microbiota transplantation (FMT), engineered bacteria, and microbiota-derived metabolites aimed at rebalancing microbial ecosystems. They are being developed for a wide range of conditions, including metabolic disorders, immune dysfunction, neurological diseases, inflammatory bowel disease (IBD), and as adjuncts to cancer immunotherapy. Compared to traditional pharmaceuticals, microbiome-based therapies offer high specificity, personalization, and long-term safety, making them the “fourth therapeutic modality” following small molecules, biologics, and cell/gene therapies.

As the global push for personalized medicine, chronic disease management, and immune-oncology adjunct therapies gains momentum, microbiome therapeutics is entering a critical commercialization window. Regulatory agencies such as the FDA and EMA are streamlining approval pathways for live biotherapeutic products (LBPs), while landmark approvals of Rebyota and Vowst mark a turning point. Strategic alliances between biotech startups and global pharma are accelerating late-stage clinical programs, supported by both capital and platform synergies.

Despite its transformative potential, the microbiome therapeutics sector faces multiple uncertainties. Manufacturing and regulatory frameworks remain inconsistent across countries, slowing clinical translation. Microbiota therapies face inherent variability and complexity, posing challenges in standardizing efficacy and trial design. Technical bottlenecks in sample sourcing, cold-chain logistics, and microbial viability maintenance elevate development costs. Additionally, market education and patient acceptance still require time, particularly in emerging regions like Asia, where applications are largely limited to early-stage R&D and clinical trials.

Demand is expanding beyond gastrointestinal conditions into systemic diseases such as IBD, recurrent Clostridioides difficile infection (CDI), cancer immunotherapy, Parkinson’s, and autism spectrum disorders. Partnerships between CROs and pharma are intensifying, while genomics, metabolomics, and AI are enabling high-throughput microbial strain screening. The clinical sector is seeking more reproducible, orally deliverable LBPs and microbiome-derived metabolite products, which align with industrial scalability. With public and private insurers beginning to cover these new modalities, microbiome therapeutics is on the path to becoming a standard pillar of precision medicine.

This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics.

The Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Microbiome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Microbiome Therapeutics Market Report

Report Metric	Details
Report Name	Microbiome Therapeutics Market
Accounted market size in year	US$ 568 million
Forecasted market size in 2031	US$ 3351 million
CAGR	30.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Upper GIT Lower GIT
Segment by Application	C. difficile Infection (CDI) Inflammatory Bowel Disease (IBD) Orphan Drug Immuno-oncology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Finch Therapeutics, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, Ferring, C3 Jian, Rebiotix, MicroBiome Therapeutics LLC, Metabiomics, Ritter Pharmaceuticals, Symberix, OpenBiome, Azitra, Symbiotix Biotherapies, Vedanta Biosciences, Metabogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Microbiome Therapeutics Market growing?

Ans: The Microbiome Therapeutics Market witnessing a CAGR of 30.5% during the forecast period 2025-2031.

What is the Microbiome Therapeutics Market size in 2031?

Ans: The Microbiome Therapeutics Market size in 2031 will be US$ 3351 million.

Who are the main players in the Microbiome Therapeutics Market report?

Ans: The main players in the Microbiome Therapeutics Market are Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Finch Therapeutics, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, Ferring, C3 Jian, Rebiotix, MicroBiome Therapeutics LLC, Metabiomics, Ritter Pharmaceuticals, Symberix, OpenBiome, Azitra, Symbiotix Biotherapies, Vedanta Biosciences, Metabogen

What are the Application segmentation covered in the Microbiome Therapeutics Market report?

Ans: The Applications covered in the Microbiome Therapeutics Market report are C. difficile Infection (CDI), Inflammatory Bowel Disease (IBD), Orphan Drug, Immuno-oncology, Others

What are the Type segmentation covered in the Microbiome Therapeutics Market report?

Ans: The Types covered in the Microbiome Therapeutics Market report are Upper GIT, Lower GIT

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Upper GIT

1.2.3 Lower GIT

1.3 Market by Application

1.3.1 Global Microbiome Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 C. difficile Infection (CDI)

1.3.3 Inflammatory Bowel Disease (IBD)

1.3.4 Orphan Drug

1.3.5 Immuno-oncology

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microbiome Therapeutics Market Perspective (2020-2031)

2.2 Global Microbiome Therapeutics Growth Trends by Region

2.2.1 Global Microbiome Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Microbiome Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Microbiome Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Microbiome Therapeutics Market Dynamics

2.3.1 Microbiome Therapeutics Industry Trends

2.3.2 Microbiome Therapeutics Market Drivers

2.3.3 Microbiome Therapeutics Market Challenges

2.3.4 Microbiome Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microbiome Therapeutics Players by Revenue

3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Top Microbiome Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Microbiome Therapeutics Revenue

3.4 Global Microbiome Therapeutics Market Concentration Ratio

3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2024

3.5 Global Key Players of Microbiome Therapeutics Head office and Area Served

3.6 Global Key Players of Microbiome Therapeutics, Product and Application

3.7 Global Key Players of Microbiome Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapeutics Breakdown Data by Type

4.1 Global Microbiome Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2026-2031)

5 Microbiome Therapeutics Breakdown Data by Application

5.1 Global Microbiome Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Microbiome Therapeutics Market Size (2020-2031)

6.2 North America Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Microbiome Therapeutics Market Size by Country (2020-2025)

6.4 North America Microbiome Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microbiome Therapeutics Market Size (2020-2031)

7.2 Europe Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Microbiome Therapeutics Market Size by Country (2020-2025)

7.4 Europe Microbiome Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Microbiome Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Microbiome Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Microbiome Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Microbiome Therapeutics Market Size (2020-2031)

9.2 Latin America Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Microbiome Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Microbiome Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microbiome Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Microbiome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Microbiome Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Seres Therapeutics

11.1.1 Seres Therapeutics Company Details

11.1.2 Seres Therapeutics Business Overview

11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction

11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2020-2025)

11.1.5 Seres Therapeutics Recent Development

11.2 Assembly Biosciences

11.2.1 Assembly Biosciences Company Details

11.2.2 Assembly Biosciences Business Overview

11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction

11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2020-2025)

11.2.5 Assembly Biosciences Recent Development

11.3 Synthetic Biologics

11.3.1 Synthetic Biologics Company Details

11.3.2 Synthetic Biologics Business Overview

11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction

11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2020-2025)

11.3.5 Synthetic Biologics Recent Development

11.4 Finch Therapeutics

11.4.1 Finch Therapeutics Company Details

11.4.2 Finch Therapeutics Business Overview

11.4.3 Finch Therapeutics Microbiome Therapeutics Introduction

11.4.4 Finch Therapeutics Revenue in Microbiome Therapeutics Business (2020-2025)

11.4.5 Finch Therapeutics Recent Development

11.5 PureTech

11.5.1 PureTech Company Details

11.5.2 PureTech Business Overview

11.5.3 PureTech Microbiome Therapeutics Introduction

11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2020-2025)

11.5.5 PureTech Recent Development

11.6 Synlogic

11.6.1 Synlogic Company Details

11.6.2 Synlogic Business Overview

11.6.3 Synlogic Microbiome Therapeutics Introduction

11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2020-2025)

11.6.5 Synlogic Recent Development

11.7 Enterome BioScience

11.7.1 Enterome BioScience Company Details

11.7.2 Enterome BioScience Business Overview

11.7.3 Enterome BioScience Microbiome Therapeutics Introduction

11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2020-2025)

11.7.5 Enterome BioScience Recent Development

11.8 4D Pharma

11.8.1 4D Pharma Company Details

11.8.2 4D Pharma Business Overview

11.8.3 4D Pharma Microbiome Therapeutics Introduction

11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2020-2025)

11.8.5 4D Pharma Recent Development

11.9 Second Genome

11.9.1 Second Genome Company Details

11.9.2 Second Genome Business Overview

11.9.3 Second Genome Microbiome Therapeutics Introduction

11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2020-2025)

11.9.5 Second Genome Recent Development

11.10 Ferring

11.10.1 Ferring Company Details

11.10.2 Ferring Business Overview

11.10.3 Ferring Microbiome Therapeutics Introduction

11.10.4 Ferring Revenue in Microbiome Therapeutics Business (2020-2025)

11.10.5 Ferring Recent Development

11.11 C3 Jian

11.11.1 C3 Jian Company Details

11.11.2 C3 Jian Business Overview

11.11.3 C3 Jian Microbiome Therapeutics Introduction

11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2020-2025)

11.11.5 C3 Jian Recent Development

11.12 Rebiotix

11.12.1 Rebiotix Company Details

11.12.2 Rebiotix Business Overview

11.12.3 Rebiotix Microbiome Therapeutics Introduction

11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2020-2025)

11.12.5 Rebiotix Recent Development

11.13 MicroBiome Therapeutics LLC

11.13.1 MicroBiome Therapeutics LLC Company Details

11.13.2 MicroBiome Therapeutics LLC Business Overview

11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction

11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2020-2025)

11.13.5 MicroBiome Therapeutics LLC Recent Development

11.14 Metabiomics

11.14.1 Metabiomics Company Details

11.14.2 Metabiomics Business Overview

11.14.3 Metabiomics Microbiome Therapeutics Introduction

11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2020-2025)

11.14.5 Metabiomics Recent Development

11.15 Ritter Pharmaceuticals

11.15.1 Ritter Pharmaceuticals Company Details

11.15.2 Ritter Pharmaceuticals Business Overview

11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction

11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2020-2025)

11.15.5 Ritter Pharmaceuticals Recent Development

11.16 Symberix

11.16.1 Symberix Company Details

11.16.2 Symberix Business Overview

11.16.3 Symberix Microbiome Therapeutics Introduction

11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2020-2025)

11.16.5 Symberix Recent Development

11.17 OpenBiome

11.17.1 OpenBiome Company Details

11.17.2 OpenBiome Business Overview

11.17.3 OpenBiome Microbiome Therapeutics Introduction

11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2020-2025)

11.17.5 OpenBiome Recent Development

11.18 Azitra

11.18.1 Azitra Company Details

11.18.2 Azitra Business Overview

11.18.3 Azitra Microbiome Therapeutics Introduction

11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2020-2025)

11.18.5 Azitra Recent Development

11.19 Symbiotix Biotherapies

11.19.1 Symbiotix Biotherapies Company Details

11.19.2 Symbiotix Biotherapies Business Overview

11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Introduction

11.19.4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2020-2025)

11.19.5 Symbiotix Biotherapies Recent Development

11.20 Vedanta Biosciences

11.20.1 Vedanta Biosciences Company Details

11.20.2 Vedanta Biosciences Business Overview

11.20.3 Vedanta Biosciences Microbiome Therapeutics Introduction

11.20.4 Vedanta Biosciences Revenue in Microbiome Therapeutics Business (2020-2025)

11.20.5 Vedanta Biosciences Recent Development

11.21 Metabogen

11.21.1 Metabogen Company Details

11.21.2 Metabogen Business Overview

11.21.3 Metabogen Microbiome Therapeutics Introduction

11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2020-2025)

11.21.5 Metabogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Seres Therapeutics

Assembly Biosciences

Synthetic Biologics

PureTech

Synlogic

Enterome BioScience

4D Pharma

Second Genome

C3 Jian

Rebiotix

MicroBiome Therapeutics LLC

Metabiomics

Ritter Pharmaceuticals

Symberix

OpenBiome

Azitra

Symbiotix Biotherapies

Metabogen

Finch Therapeutics

Ferring

Vedanta Biosciences

List of Tables

Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Upper GIT

Table 3. Key Players of Lower GIT

Table 4. Global Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Microbiome Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Microbiome Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Microbiome Therapeutics Market Share by Region (2020-2025)

Table 8. Global Microbiome Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Microbiome Therapeutics Market Share by Region (2026-2031)

Table 10. Microbiome Therapeutics Market Trends

Table 11. Microbiome Therapeutics Market Drivers

Table 12. Microbiome Therapeutics Market Challenges

Table 13. Microbiome Therapeutics Market Restraints

Table 14. Global Microbiome Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Microbiome Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2024)

Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Microbiome Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Microbiome Therapeutics, Product and Application

Table 21. Global Key Players of Microbiome Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Microbiome Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Microbiome Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Microbiome Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Microbiome Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Microbiome Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Microbiome Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Microbiome Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Microbiome Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Seres Therapeutics Company Details

Table 47. Seres Therapeutics Business Overview

Table 48. Seres Therapeutics Microbiome Therapeutics Product

Table 49. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 50. Seres Therapeutics Recent Development

Table 51. Assembly Biosciences Company Details

Table 52. Assembly Biosciences Business Overview

Table 53. Assembly Biosciences Microbiome Therapeutics Product

Table 54. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Assembly Biosciences Recent Development

Table 56. Synthetic Biologics Company Details

Table 57. Synthetic Biologics Business Overview

Table 58. Synthetic Biologics Microbiome Therapeutics Product

Table 59. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Synthetic Biologics Recent Development

Table 61. Finch Therapeutics Company Details

Table 62. Finch Therapeutics Business Overview

Table 63. Finch Therapeutics Microbiome Therapeutics Product

Table 64. Finch Therapeutics Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Finch Therapeutics Recent Development

Table 66. PureTech Company Details

Table 67. PureTech Business Overview

Table 68. PureTech Microbiome Therapeutics Product

Table 69. PureTech Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 70. PureTech Recent Development

Table 71. Synlogic Company Details

Table 72. Synlogic Business Overview

Table 73. Synlogic Microbiome Therapeutics Product

Table 74. Synlogic Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Synlogic Recent Development

Table 76. Enterome BioScience Company Details

Table 77. Enterome BioScience Business Overview

Table 78. Enterome BioScience Microbiome Therapeutics Product

Table 79. Enterome BioScience Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Enterome BioScience Recent Development

Table 81. 4D Pharma Company Details

Table 82. 4D Pharma Business Overview

Table 83. 4D Pharma Microbiome Therapeutics Product

Table 84. 4D Pharma Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 85. 4D Pharma Recent Development

Table 86. Second Genome Company Details

Table 87. Second Genome Business Overview

Table 88. Second Genome Microbiome Therapeutics Product

Table 89. Second Genome Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Second Genome Recent Development

Table 91. Ferring Company Details

Table 92. Ferring Business Overview

Table 93. Ferring Microbiome Therapeutics Product

Table 94. Ferring Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Ferring Recent Development

Table 96. C3 Jian Company Details

Table 97. C3 Jian Business Overview

Table 98. C3 Jian Microbiome Therapeutics Product

Table 99. C3 Jian Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 100. C3 Jian Recent Development

Table 101. Rebiotix Company Details

Table 102. Rebiotix Business Overview

Table 103. Rebiotix Microbiome Therapeutics Product

Table 104. Rebiotix Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Rebiotix Recent Development

Table 106. MicroBiome Therapeutics LLC Company Details

Table 107. MicroBiome Therapeutics LLC Business Overview

Table 108. MicroBiome Therapeutics LLC Microbiome Therapeutics Product

Table 109. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 110. MicroBiome Therapeutics LLC Recent Development

Table 111. Metabiomics Company Details

Table 112. Metabiomics Business Overview

Table 113. Metabiomics Microbiome Therapeutics Product

Table 114. Metabiomics Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 115. Metabiomics Recent Development

Table 116. Ritter Pharmaceuticals Company Details

Table 117. Ritter Pharmaceuticals Business Overview

Table 118. Ritter Pharmaceuticals Microbiome Therapeutics Product

Table 119. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 120. Ritter Pharmaceuticals Recent Development

Table 121. Symberix Company Details

Table 122. Symberix Business Overview

Table 123. Symberix Microbiome Therapeutics Product

Table 124. Symberix Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 125. Symberix Recent Development

Table 126. OpenBiome Company Details

Table 127. OpenBiome Business Overview

Table 128. OpenBiome Microbiome Therapeutics Product

Table 129. OpenBiome Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 130. OpenBiome Recent Development

Table 131. Azitra Company Details

Table 132. Azitra Business Overview

Table 133. Azitra Microbiome Therapeutics Product

Table 134. Azitra Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 135. Azitra Recent Development

Table 136. Symbiotix Biotherapies Company Details

Table 137. Symbiotix Biotherapies Business Overview

Table 138. Symbiotix Biotherapies Microbiome Therapeutics Product

Table 139. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 140. Symbiotix Biotherapies Recent Development

Table 141. Vedanta Biosciences Company Details

Table 142. Vedanta Biosciences Business Overview

Table 143. Vedanta Biosciences Microbiome Therapeutics Product

Table 144. Vedanta Biosciences Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 145. Vedanta Biosciences Recent Development

Table 146. Metabogen Company Details

Table 147. Metabogen Business Overview

Table 148. Metabogen Microbiome Therapeutics Product

Table 149. Metabogen Revenue in Microbiome Therapeutics Business (2020-2025) & (US$ Million)

Table 150. Metabogen Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Microbiome Therapeutics Picture

Figure 2. Global Microbiome Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Microbiome Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Upper GIT Features

Figure 5. Lower GIT Features

Figure 6. Global Microbiome Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Microbiome Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. C. difficile Infection (CDI) Case Studies

Figure 9. Inflammatory Bowel Disease (IBD) Case Studies

Figure 10. Orphan Drug Case Studies

Figure 11. Immuno-oncology Case Studies

Figure 12. Others Case Studies

Figure 13. Microbiome Therapeutics Report Years Considered

Figure 14. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Microbiome Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Microbiome Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Microbiome Therapeutics Market Share by Players in 2024

Figure 18. Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2024

Figure 20. North America Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Ireland Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Microbiome Therapeutics Market Share by Region (2020-2031)

Figure 34. China Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia & New Zealand Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Microbiome Therapeutics Market Share by Country (2020-2031)

Figure 46. Israel Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Microbiome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 50. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 51. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 52. Finch Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 53. PureTech Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 54. Synlogic Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 55. Enterome BioScience Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 56. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 57. Second Genome Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 58. Ferring Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 59. C3 Jian Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 60. Rebiotix Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 61. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 62. Metabiomics Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 63. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 64. Symberix Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 65. OpenBiome Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 66. Azitra Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 67. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 68. Vedanta Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 69. Metabogen Revenue Growth Rate in Microbiome Therapeutics Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Microbiome Modulators Market Insights Forecast to 2030

Human Microbiome Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Microbiome Analysis Market Research Report 2024

Global Microbiome Cosmetic Market Research Report 2025

Global Microbiome Drugs Market Research Report 2024

Microbiome Skincare Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Probiotics Gummies Market Research Report 2025

Global Microbiome Therapies Market Research Report 2024

Global Human Microbiome Sequencing Services Market Research Report 2024

Microbiome Beauty Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Skin Microbiome Modulator Market Research Report 2025

Global Microbial Regulators in Human Body Market Research Report 2024

Agriculture Microbiome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Microbial Control Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Probiotics Capsule and Powder Market Research Report 2024

Global Microbiomes Market Research Report 2024

Medicinal Microbiology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Crop Microbiome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Microbiome Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions